During the past decade, Prisma Health Cancer Institute - Butternut conducted 151 clinical trials. In the 10-year time frame, 151 clinical trials started and 115 clinical trials were completed, i.e. on average, 76.2% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 75 clinical trials were completed. i.e. 153.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Cancer Institute - Butternut" #1 sponsor was "National Cancer Institute (NCI)" with 91 trials, followed by "SWOG Cancer Research Network" with 57 trials sponsored, "Alliance for Clinical Trials in Oncology" with 51 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Wake Forest University Health Sciences" with 15 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Cancer Institute - Butternut" #1 collaborator was "National Cancer Institute (NCI)" with 156 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Cancer Institute - Butternut" are "Breast Cancer" (16 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Colorectal Cancer" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Prisma Health Cancer Institute - Butternut" in a lesser frequency.

Most popular intervention types in "Prisma Health Cancer Institute - Butternut" are "Drug" (185 trials), "Other" (169 trials), "Biological" (86 trials), "Procedure" (49 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (78 trials), "Quality-of-Life Assessment" (61 trials), "Questionnaire Administration" (43 trials), "Cisplatin" (23 trials) and "Carboplatin" (22 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Cancer Institute - Butternut" are 202 trials for "All" genders, 41 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Prisma Health Cancer Institute - Butternut". undefined are not yet recruiting, 49 are recruiting, 115 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 68 completed trials in Prisma Health Cancer Institute - Butternut, 4 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Cancer Institute - Butternut, 6 "Phase 1" clinical trials were conducted, 99 "Phase 2" clinical trials and 126 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 17 trials that are defined as “Not Applicable".